Bachem Holding AG
BANB
Company Profile
Business description
Bachem Holding AG is a biochemical company that provides services to the pharmaceutical and biotechnology industry. It focuses on specializing in the development and manufacture of peptides and oligonucleotides. The group markets its products under the Bachem and Clinalfa brands. It has two geographic segments Europe/Asia and North America. Its products and services are CMC Development, Commercial API, Research and Specialities, and Services and Capabilities.
Contact
Hauptstrasse 144
Bubendorf4416
CHET: +41 585952021
Sector
Basic Materials
Stock type
Cyclical
Industry
Chemicals
Fiscal Year End
31 December 2025
Employees
2,009
Stocks News & Analysis
stocks
Is this ASX share a long-term buy?
Current operating conditions are challenging but over the long-term prospects are better.
stocks
Why Guzman and Reece's share reversals have a lot in common
Investors must weigh exciting growth stories against competitive dynamics and the price they are being asked to pay.
stocks
Going into earnings, is Nvidia stock a buy, a sell, or fairly valued?
Watching the data centre business and the debate around it, here’s what we think of Nvidia stock.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,477.30 | 20.70 | -0.24% |
| CAC 40 | 8,126.26 | 75.19 | 0.93% |
| DAX 40 | 22,701.96 | 291.69 | 1.30% |
| Dow JONES (US) | 43,621.16 | 159.95 | 0.37% |
| FTSE 100 | 8,708.74 | 40.07 | 0.46% |
| HKSE | 23,787.93 | 753.91 | 3.27% |
| NASDAQ | 19,026.39 | 260.54 | -1.35% |
| Nikkei 225 | 38,142.37 | 95.42 | -0.25% |
| NZX 50 Index | 12,452.46 | 145.19 | 1.18% |
| S&P 500 | 5,955.25 | 0.00 | 0.00% |
| S&P/ASX 200 | 8,240.70 | 11.20 | -0.14% |
| SSE Composite Index | 3,380.21 | 34.17 | 1.02% |